This research was designed to evaluate the effect of monensin (Elanco Animal Health, Greenfield, IN) supplementation via mineral or pressed protein block with or without a growth-promoting implant on performance of steers grazing wheat pasture in Arkansas over 2 yr. Preconditioned steers (n = 360, BW = 238 ± 5.1 kg) grazed 15 1.6-ha wheat pastures in the fall (n = 60 steers each fall, stocking rate of 2.5 steers/ha) or 30 0.8-ha wheat pastures in the spring (n = 120 steers each spring, stocking rate of 5 steers/ha). Steers in each pasture were given free-choice access to nonmedicated mineral (CNTRL; MoorMan's WeatherMaster Range Minerals A 646AAA; ADM Alliance Nutrition, Inc., Quincy, IL), or were supplemented with monensin (Elanco Animal Health, Greenfield, IN) via mineral containing 1.78 g monensin/kg (RMIN; MoorMan's Grower Mineral RU-1620 590AR; ADM Alliance Nutrition, Inc.), or pressed protein block containing 0.33 g monensin/kg (RBLCK; MoorMan's Mintrate Blonde Block RU; ADM Alliance Nutrition, Inc.). Additionally, one-half of the steers in each pasture were implanted (IMPL) with 40 mg trenbolone acetate and 8 mg estradiol (Component TE-G with Tylan; Elanco Animal Health). There was no interaction (P ≥ 0.71) between supplement treatment and growth-promoting implants, and ADG for RMIN and RBLCK were increased (P < 0.01) over CNTRL by 0.07 to 0.09 kg/d, respectively. Implanting steers with Component TE-G increased (P < 0.01) ADG by 0.14 kg/d. The combination of these growth-promoting technologies are a cost-effective means of increasing beef production by 22% without increasing level of supplementation or pasture acreage. Utilizing ionophores and implants together for wheat pasture stocker cattle decreased cost of gain by 26%. Utilizing both IMPL and monensin increased net return by $30 to $54/steer for RMIN or $18 to $43/steer for RBLCK compared with UNIMPL CNTRL at Low and High values of BW gain, respectively.

Fourteen crossbred wether lambs (average BW, 28 kg +/- 2.3) were either implanted (12 mg of zeranol) or not implanted and group-fed an 86% concentrate diet for 21 d. Lambs were then moved to metabolism stalls and fed .8 kg/d for a 10-d stall adjustment followed by a 7-d total collection of feces and urine. Feed, feces and urine were analyzed for Ca, P, Mg, Zn, Mn, Cu, and N. Apparent absorption of Mn, Cu, and N, were similar for implanted and nonimplanted lambs. Zeranol did not affect (P > .10) the retention of Mn or Cu. Zeranol decreased fecal excretion of CA 22% (P < .01), P 27% (P < .05), Mg 11% (P < .03) and Zn 9% (P < .10). This increased apparent absorption of CA 88% (P < .01), P 193% ( P < .05), Mg 9% (P < .05) and Zn 45% (P < .10) in zeranol-treated lambs. Urinary excretion of all nutrients analyzed was similar for implanted and control lambs with the exception of N, which was reduced by 24% (P < .06) in implanted lambs. The amount of Ca, Mg, and Zn retained increased 98% (P < .01), 138% (P < .03), and 60% (P < .10), respectively, in implanted lambs compared with controls. These results indicate that zeranol improved N balance and enhanced the absorption and retention of Ca, P, Mg, and Zn in lambs.

Forty crossbred wethers (average weight 30 kg) were implanted with zeranol (12 mg) at 30-d intervals and fed at two levels of intake in a 2 x 2 factorial arrangement of treatments to determine performance, carcass and bone characteristics, blood metabolites, and hormones. Restricted lambs were fed to gain one-half the BW gained by lambs with ad libitum feed access. Lambs with ad libitum and restricted access to feed were slaughtered after 98 and 154 d, respectively. Zeranol increased ADG (P = .047; 20%), gain to feed (P = .023; 17%), metacarpal length (P = .004; 6%) and weight (P = .013; 13%), and tended to increase carcass crude protein gain (P = .106; 63%) while reducing kidney pelvic fat (P = .001; 33%) and dressing percentage (P = .038; 3%). Restricted feed intake increased the percentage of carcass ash and metacarpal length and weight by 27% (P = .048), 5% (P = .006), and 10% (P = .045), respectively, while reducing quality grade scores (P = .022; 5%), gain to feed (P = .001; 49%), longissimus muscle area (P = .001; 28%), the percentage of kidney pelvic fat (P = .033; 13%), and daily fat gain (P = .001; 54%). Zeranol increased pituitary weight (P = .001; 166%), plasma glucose (P = .036; 13%), mean serum growth hormone (GH; P = .011; 52%), baseline GH (P = .048; 34%), GH pulse amplitude (P = .003; 59%), and IGF-I (P = .001; 53%) concentrations. The results indicate that continuous administration of zeranol from 60 d of age to slaughter increases GH release, which directs nutrient utilization such that a carcass with more desirable lean and fat deposition patterns is obtained when nutrient availability is adequate.

The objective of this study was to evaluate a combination of best management practices strategy for steer calves grazing tall fescue pastures with a range of toxicity. The experiment was conducted over two grazing seasons (fall 2015 for 91 days and spring 2016 for 84 days). Steers (n = 80 within season, BW = 197.0 ± 15.43 kg [fall] and 116.9 ± 4.88 [spring]) were stocked at 2.45 and 4.1 calves/hectare in fall and spring, respectively, to 16 pastures with varying levels of toxicity based on interim ergovaline (EV) concentration within season. Pastures were assigned to either mineral (MIN, n = 8) only management (MGMT) or a cumulative MGMT (CM, n = 8). The CM treatment included an implant containing 40 mg trenbolone acetate, 8 mg estradiol, and 29 mg tylosin tartrate (Component TE-G with Tylan, Elanco Animal Health, Greenfield, IN), 150 mg/calf daily monensin (Elanco Animal Health), and 1% body weight (BW) of a 50:50 corn gluten feed:soybean hull supplement (as-is basis). Data were analyzed within season using pasture as the experimental unit. For fall and spring, the EV concentration was 1,476 ± 883.2 ppb and 1,173 ± 620.6 ppb, respectively, and ranged from 90 ppb to 2,180 ppb. During the fall, forage allowance did not differ (P = 0.76) between CM and MIN. In the spring, however, forage allowance only differed for the month of June (P ≤ 0.05, 2.55 versus 3.22 ± 0.177 kg DM/kg BW, for MIN and CM, respectively). In the fall, average daily gain (ADG) responded to the simple effects of EV (P = 0.01) and MGMT (P < 0.001), and ADG for MIN steers was explained by ADG = 0.41 - 0.000064 × EV; whereas, ADG for CM was explained by ADG = 1.05 - 0.000064 × EV. In the spring, there was an EV × MGMT interaction (P = 0.03) for ADG. For MIN, ADG = 0.80 - 0.000278 × EV; whereas for CM, ADG = 0.94 + 0.000001835 × EV. In spring, the ADG response to CM relative to MIN increased as EV increased. The CM strategy resulted in lower blood urea nitrogen than MIN in fall and spring (P < 0.01), but prolactin and serum Cu were not affected by MGMT in either season. In conclusion, performance was improved within the fescue belt by implementing feeding strategies using implants, ionophores and supplementation, but a detailed economic analysis is warranted. Further research is needed to evaluate CM programs under varied stocking rates and in combination with dilution of endophyte-infected fescue pastures with non-toxic grasses or legumes.

No abstract